Literature DB >> 22504413

TLR3 and RIG-I gene variants: associations with functional effects on receptor expression and responses to measles virus and vaccine in vaccinated infants.

Holly D Clifford1, Stephanie T Yerkovich, Siew-Kim Khoo, Guicheng Zhang, John Upham, Peter N Le Souëf, Peter Richmond, Catherine M Hayden.   

Abstract

Measles virus causes severe morbidity and mortality, despite the availability of measles vaccines. Successful defence against viral pathogens requires early recognition of virus-specific patterns by innate receptors like Toll-like receptor (TLR)3 and the RNA helicase, retinoic acid inducible gene-I (RIG-I). Genetic differences in these receptors may influence the primary immune responses to measles and the efficacy of measles vaccine. In 1-year-old Australian infants after their first measles vaccine dose, we investigated functional effects of TLR3 and RIG-I polymorphisms on intracellular protein expression using flow cytometry, cytokine responses to receptor ligands and measles lysate, and post-vaccination measles IgG levels. We found that TLR3 Leu412Phe was significantly associated with IFN-α/β response after stimulation with TLR3 ligand, poly(I:C) (P=0.024). Downregulation of TLR3 protein expression in NK cells after poly(I:C) was also associated with this variant (P=0.011). In contrast, measles-specific expression, cytokine responses and antibody responses were not associated with TLR3 polymorphisms. No associations were found with RIG-I variants. These results suggest that a TLR3 polymorphism has functional effects on receptor expression and cytokine response. However, this did not translate to an effect on specific responses to measles virus or vaccine. We found no evidence that RIG-I polymorphisms were involved in measles immune responses. Crown
Copyright © 2012. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22504413     DOI: 10.1016/j.humimm.2012.03.004

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  9 in total

1.  Changing face of vaccination in immunocompromised hosts.

Authors:  Daire O'Shea; Lukas A Widmer; Jörg Stelling; Adrian Egli
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

Review 2.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

Review 3.  Variability in Humoral Immunity to Measles Vaccine: New Developments.

Authors:  Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Jennifer A Whitaker; Gregory A Poland
Journal:  Trends Mol Med       Date:  2015-11-18       Impact factor: 11.951

Review 4.  The personal touch: strategies toward personalized vaccines and predicting immune responses to them.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Nathaniel D Lambert; Iana H Haralambieva; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2014-04-04       Impact factor: 5.217

5.  Genetic associations with a fever after measles-containing vaccines.

Authors:  Nicola P Klein; Ousseny Zerbo; Kristin Goddard; Weiqi Wang; Alison E Fohner; Amy Wiesner; Vida Shokoohi; John Coller; Karin Bok; Hayley A Gans
Journal:  Hum Vaccin Immunother       Date:  2020-12-22       Impact factor: 3.452

Review 6.  Current perspectives in assessing humoral immunity after measles vaccination.

Authors:  Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Daniel J Schaid; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2018-12-26       Impact factor: 5.683

Review 7.  The genetic regulation of infant immune responses to vaccination.

Authors:  Melanie J Newport
Journal:  Front Immunol       Date:  2015-02-02       Impact factor: 7.561

8.  Increased expression of retinoic acid-induced gene 1 in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression.

Authors:  Johannes Haybaeck; Magdalena Postruznik; Christine L Miller; Jeannette R Dulay; Ida C Llenos; Serge Weis
Journal:  Neuropsychiatr Dis Treat       Date:  2015-02-04       Impact factor: 2.570

9.  Parental risk factors for fever in their children 7-10 days after the first dose of measles-containing vaccines.

Authors:  Ousseny Zerbo; Sharareh Modaressi; Kristin Goddard; Edwin Lewis; Karin Bok; Hayley Gans; Nicola P Klein
Journal:  Hum Vaccin Immunother       Date:  2019-11-08       Impact factor: 3.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.